top of page
OUR CAPABILITIES
Pluripotent and Reporter Cell Lines
StemCore has exclusive rights and ownership of the NIH approved MEL hESC, reporter stem cell and hiPSC lines. Cell stocks are provided on a cost recovery basis together with highly detailed product information sheets for quality assurance.
Coming soon
Female iPSC lines
Well characterised female hiPSC control lines for your research
MEL-2 GcAMP hESCs
A reporter cell line generated using MEL-2 Chassis and RMCE to track cardiomyocyte differentiation
MEL-2 Chassis hESCs
For generating a reporter cell line qucikly using RMCE (Recombinase Mediated Cassette Exchange)
CRISPRa / CRISPRi line
CRISPR-Cas9 based precise up- or down-regulation of genes without gene editing
bottom of page